MELCAYA will implement a
Pan-European
second opinion platform
MELCAYA will create a skin & breath
volatilomics tool
MELCAYA will develop AI and ML
tools for prediction
and diagnosis

In childhood, adolescence and young adults (CAYA), melanoma is under-studied and non-existing tailored clinical guidelines and standardized approaches lead to a very low diagnostic accuracy. Against this background, the MELCAYA project aims to understand risk factors and determinants of melanoma to improve the prevention, diagnosis and prognosis of melanomas in CAYA. To achieve these goals, the project will implement the following approaches. 

1) By integrating existing reference European cohorts and registries, studies of genetic and environmental risk factors and progression of melanoma in CAYA will be performed through different omic methods, and a novel taxonomy of CAYA melanoma will be generated. 2) MELCAYA will develop image-based robust and trustworthy machine learning tools and a pan-European second-opinion platform for better diagnosis specifically designed for CAYA. 3) Moreover, the validation of minimally and non-invasive disruptive tools based on artificial intelligence and volatilomics detection from exhaled breath and skin will lead to earlier detection and more accurate prognosis of melanoma in CAYA. 4) Finally, through the evidence gathered, MELCAYA will design and implement public health strategies and will actively involve patients and the general population. The results of MELCAYA will maximize its impact by making its data and results accessible and re-usable through integration into UNCAN.eu.

Subscribe to our Newsletter!
Discover our latest updates and news about the MELCAYA project.
identify

environmental and genetic risk factors for melanoma in CAYA.

establish

molecular profiles of progression from benign congenital nevi to melanoma.

facilitate

better international collaboration, standards, and melanoma taxonomy.

evaluate

the clinical efficacy and safety of anti-PD1 antibodies in CAYA melanoma patients.

develop

an AI-based diagnostic tool to distinguish the images of melanomas from images of nevi or other benign pigmented skin lesions.

conduct

rapid and non-invasive tools for risk and prognosis of melanoma in CAYA.

design

health care system strategies on prevention and diagnosis of melanoma.

ensure

patient research engagement and education throughout the project and its implementation.

Nutrition

Nobis noster graeco no vis, mazim explicari comprehensam sea id. Sit ullum delectus.

Nobis noster graeco no vis, mazim explicari comprehensam sea id. Sit ullum delectus.

Nobis noster graeco no vis, mazim explicari comprehensam sea id. Sit ullum delectus.

Nobis noster graeco no vis, mazim explicari comprehensam sea id. Sit ullum delectus.

Debet legendos eleifend ei sit. Viderer indoctum an has, mediocrem ex sit, tamquam alterum delicatissimi vim ei, est ex ubique reprehendunt. Tacimates maiestatis nec et, est at virtute prodesset reformidans, nisl eleifend nec ne. Justo molestiae constituto eam ut. Sit ne perfecto contentiones, cu nostrum senserit mea. Modo invenire vix an.

Play Video

* BMR Metabolic Rate / BMI Body Mass Index

bmi
weight status

Below 18.5 18.5 - 24.9 25.0 - 29.9

30.0 - and Above

Underweight Healthy Overweight Obese

Please enter valid form ID

Julie Williams

Core, Personal trainer

Frank Lyman

Bodybuilding coach

Molly Peters

Cardio & Conditioning

Warren Bower

Yoga Instructor

Debet legendos eleifend ei sit. Viderer indoctum an has, mediocrem ex sit, tamquam alterum delicatissimi vim ei, est ex ubique reprehendunt. Tacimates maiestatis nec et, est at virtute prodesset reformidans, nisl eleifend nec ne. Justo molestiae constituto eam ut. Sit ne perfecto contentiones. Cu nostrum senserit mea modo invenire vix an no pri animal latine consulatu, mei in officiis ponderum principes, et his diam salutandi. 

$ 35
Per day

daily ticket

  1. Quo at ullum perpetua, dicta graecis oportere sea id. Mea et natum accusam, has an inimicus senserit. Utroque honestatis at vim his te.
$ 105
Per month

12 month's membership

  1. Quo at ullum perpetua, dicta graecis oportere sea id. Mea et natum accusam, has an inimicus senserit. Utroque honestatis at vim his te.
Please enter valid form ID

No posts were found for provided query parameters.

Tellus cras adipiscing enim eu turpis. Platea dictumst vestibulum rhoncus est pell entesque.

Rick Greenwalt

Et egestas quis ipsum sendisse ultrices gravida dictum. Placerat vestibulum lectus mauris ultrices.

Bernard Curtis

Massa tincidunt nunc pulvinar sapien et ligula ullamcorper malesuada. Tincidunt vitae semper.

Mark Kappel

This project has received funding from the European Health and Digital Executive Agency under grant agreement No 101096667.

Project Office

August Pi i Sunyer Biomedical Research Institute (IDIBAPS)

Campus Casanova, Casanova, 143

08036 Barcelona

Contact

email: office@melcaya.eu